Denosumab Injection Denoci 120mg Injection

Get a Price/Quote

MOQ : 10 Pieces

Denosumab Injection Denoci 120mg Injection Specification

Salt Composition
Denosumab 120mg

Indication
Osteoporosis, Bone Loss, Prevention of Skeletal-related Events in Cancer

Dosage Form
Injection

Feature
Ready to use, single-use prefilled syringe

Ingredients
Denosumab, Excipients

Application
Subcutaneous administration

Physical Color/Texture
Clear to slightly opalescent, colorless to pale yellow solution

Fermentation Smell
Odorless

Storage Instructions
Store in a refrigerator (2C - 8C), do not freeze, protect from light

Shelf Life
24 months

Pack Type
Single dose prefilled syringe

Country of Approval/Markets
Canada, EU, UK, USA, Australia

Usage
Under healthcare professional supervision only

Storage Conditions
Refrigerate, do not freeze, keep in original packaging to protect from light

Route of Administration
Subcutaneous

Therapeutic Class
Monoclonal antibody (RANKL inhibitor)

Stability
Stable under recommended storage conditions

Prescription/Non-Prescription
Prescription

Special Precautions
Ensure adequate calcium and vitamin D intake during therapy; monitor for infections and dermatological reactions

Strength
120 mg per 1.7 ml

Common Side Effects
Fatigue, joint pain, muscle pain, skin infection, hypocalcemia

Contraindications
Hypocalcemia, allergy to denosumab

About Denosumab Injection Denoci 120mg Injection

Experience exceptional effectiveness with the newly released Denosumab Injection Denoci 120mg. This monoclonal antibody (RANKL inhibitor) comes at an unbeatable price in a single-use, prefilled syringe for subcutaneous administration. Redeem advanced care for osteoporosis, bone loss, and prevention of skeletal-related events in cancer patients with this prescription-only medication. Stable when refrigerated and protected from light, Denoci 120mg ensures excellent safety and efficacy when used under healthcare professional supervision. This product is approved in Canada, EU, UK, USA, and Australia, showcasing its international virtuoso credentials.

Exceptional Features & Competitive Advantages

Denosumab Injection Denoci 120mg stands out for its ready-to-use, single-dose, prefilled syringe design, ensuring precise delivery and minimizing preparation time. The plant-based manufacturing guarantees consistent quality and an odorless, clear to pale yellow solution. With its stable 24-month shelf life and secure packaging, Denoci 120mg offers manufacturers, traders, and healthcare providers a competitive edge in storage and stock management, enhancing overall patient safety and convenience.

Export Markets & Order Fulfillment Details

Denosumab Injection Denoci 120mg is a leading export product to key markets such as Canada, EU, UK, USA, and Australia. Upon receipt of a formal purchase order, orders are fulfilled promptly, with a flexible payment structure tailored to client requirements. Options for express shipping and point-to-point drop-off enable timely delivery, ensuring that healthcare facilities and distribution partners receive the product efficiently and maintain continuous patient care.

FAQ's of Denosumab Injection Denoci 120mg Injection:

Q: How should Denosumab Injection Denoci 120mg be stored and handled?

A: Denosumab Denoci 120mg must be refrigerated between 2C to 8C, kept in its original packaging to protect from light, and must not be frozen for quality and stability.

Q: What are the major indications for using Denosumab Injection Denoci 120mg?

A: This medication is indicated for treating osteoporosis, bone loss, and prevention of skeletal-related events in cancer patients, administered under healthcare professional supervision.

Q: When is Denosumab Denoci 120mg contraindicated?

A: It should not be used in individuals with hypocalcemia or known allergies to denosumab. Healthcare providers must assess patients before initiating therapy.